SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-060274
Filing Date
2013-11-12
Accepted
2013-11-12 09:40:26
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v358862_10q.htm 10-Q 758186
2 EXHIBIT 31.1 v358862_ex31-1.htm EX-31.1 18137
3 EXHIBIT 32.1 v358862_ex32-1.htm EX-32.1 9883
  Complete submission text file 0001144204-13-060274.txt   3780766

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT antb-20130930.xml EX-101.INS 408727
5 XBRL TAXONOMY EXTENSION SCHEMA antb-20130930.xsd EX-101.SCH 50668
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20130930_cal.xml EX-101.CAL 30615
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20130930_def.xml EX-101.DEF 209045
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20130930_lab.xml EX-101.LAB 288320
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20130930_pre.xml EX-101.PRE 249565
Mailing Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025
Business Address 890 SANTA CRUZ AVENUE MENLO PARK CA 94025 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54495 | Film No.: 131207539
SIC: 2834 Pharmaceutical Preparations